Effects of COVID-19 vaccination and previous SARS-CoV-2 infection on omicron infection and severe outcomes in children under 12 years of age in the USA: an observational cohort study
Data on the protection conferred by COVID-19 vaccination and previous SARS-CoV-2 infection against omicron (B.1.1.529) infection in young children are scarce.
News
Policy & Recommendations
Call for action on Pandemic Prevention, Preparedness, and Response
Ahead of the UN High-level Meeting on Pandemic Prevention, Preparedness, and Response, taking place in September, ESWI has joined the Pandemic Action Network, alongside more than 90 partners, in signing a political declaration calling leaders for action.
Toward Comprehensive Care for Long Covid
The sequelae of SARS-CoV-2 infection can involve multiple organ systems and are often grouped together as “long Covid” or PASC (postacute sequelae of SARS-CoV-2)
News
Policy & Recommendations
EPHA’s priorities to strengthen public health across the EU ahead of the 2024 European elections
The European Public Health Alliance's manifesto presents five key priorities, aiming at strengthening public health and securing the EU’s resilience by working on pandemic preparedness and response.
News
Policy & Recommendations
European Commission authorises first vaccine to protect older adults from RSV infection
The EC has authorised Arexvy, the first vaccine to protect adults aged 60 years and older, against RSV. This decision marks an important step and has been particularly awaited in light of the increased RSV infections in the EU last winter.
News
Policy & Recommendations
Science and technology workforce: women in majority
In 2022, almost 76 million people in the EU aged 15 to 74 were employed in science and technology (+2.5% compared with 2021). Of the 76 million people employed in science and technology, 52% were women (no change compared with 2021).
Pandemic Preparedness. How will the international accord help respond to unforeseen shocks?
Science|Business organised a roundtable discussion with international experts -representing industry, academia, public health bodies, think tanks, government officials and research organisations- to discuss how to prepare for future pandemics.
Development of a Definition of Postacute Sequelae of SARS-CoV-2 Infection
What symptoms are differentially present in SARS-CoV-2–infected individuals 6 months or more after infection compared with uninfected individuals? What symptom-based criteria can be used to identify postacute sequelae of SARS-CoV-2 infection cases?
Diagnosis of type 1 diabetes after SARS-CoV-2 infection: Researchers find possible correlation
Researchers at Helmholtz Munich and TU Dresden, in cooperation with the Kassenärztliche Vereinigung Bayern, have now investigated whether there is a temporal association between infection with the SARS-CoV-2 virus and the development of type 1 diabetes.
Second monovalent SARS-CoV-2 mRNA booster restores Omicron-specific neutralizing activity in both nursing home residents and health care workers
Antibody levels and neutralizing activity progressively increased with each booster but subsequently waned over 3-6 months.
The impact of the SARS-CoV-2 pandemic on global influenza surveillance: Insights from 18 National Influenza Centers based on a survey conducted between November 2021 and March 2022
National Influenza Centers have played a crucial role in the surveillance of SARS-CoV-2. The FluCov project, covering 22 countries, was initiated to monitor the impact of the SARS-CoV-2 pandemic on influenza activity.
Influenza Vaccines: What Does the mRNA Platform Have to Offer?
Are you up to date about current developments in influenza vaccines with the messenger RNA (mRNA) platform?